Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Cigna Corporation (CI) Stock Price
Media coverage about Cigna Corporation (NYSE:CI) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cigna Corporation earned a coverage optimism score of 0.13 on Accern’s scale. Accern also assigned news articles about the health services provider an impact score of 44.8189455754056 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the media stories that may have effected Accern’s analysis:
- Strong Buy Ranking for Cigna (CI) Kept – Investorplace.com (investorplace.com)
- Cigna is Committed to Reducing Opioid Use: Removing OxyContin … – Business Wire (press release) (businesswire.com)
- Collegium Rallies On ‘Value-Based Contract’ With Cigna; Here’s What It Means – Benzinga (benzinga.com)
- Cigna Corporation’s Third Quarter 2017 Earnings Release Details – Business Wire (press release) (businesswire.com)
- Cigna won't cover OxyContin prescriptions for 2018 (finance.yahoo.com)
Shares of Cigna Corporation (CI) opened at 190.68 on Friday. Cigna Corporation has a 52 week low of $115.03 and a 52 week high of $193.00. The stock has a 50 day moving average of $183.54 and a 200 day moving average of $168.45. The firm has a market cap of $48.01 billion, a P/E ratio of 22.00 and a beta of 0.43.
Cigna Corporation (NYSE:CI) last released its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.43. The company had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. Cigna Corporation’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.98 EPS. Analysts anticipate that Cigna Corporation will post $10.03 earnings per share for the current fiscal year.
A number of equities research analysts have weighed in on the stock. ValuEngine downgraded shares of Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 20th. Credit Suisse Group reiterated an “outperform” rating and set a $193.00 price target (up previously from $190.00) on shares of Cigna Corporation in a research note on Friday, July 14th. Piper Jaffray Companies reiterated a “buy” rating and set a $191.00 price target on shares of Cigna Corporation in a research note on Sunday, September 17th. CIBC lifted their price target on shares of Cigna Corporation from $174.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, June 15th. Finally, Royal Bank Of Canada reiterated a “buy” rating and set a $177.00 price target on shares of Cigna Corporation in a research note on Tuesday, June 13th. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Cigna Corporation presently has a consensus rating of “Buy” and a consensus target price of $188.57.
ILLEGAL ACTIVITY WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Cigna Corporation (CI) Stock Price” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-cigna-corporation-ci-stock-price/1611296.html.
In other news, Chairman Isaiah Harris, Jr. sold 247 shares of the stock in a transaction on Tuesday, September 12th. The stock was sold at an average price of $185.27, for a total transaction of $45,761.69. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jane E. Md Henney sold 600 shares of the stock in a transaction on Monday, July 24th. The stock was sold at an average price of $174.14, for a total value of $104,484.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 70,653 shares of company stock worth $12,437,684. 1.30% of the stock is currently owned by insiders.
About Cigna Corporation
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.